ACADIA PHARMACEUTICALS INC Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Acadia Pharmaceuticals Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Acadia Pharmaceuticals Inc Debt-to-equity for the quarter ending September 30, 2024 was 75.7 %, a 17.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 75.7 +11.3 +17.6% Sep 30, 2024
Q2 2024 77.5 +21.6 +38.7% Jun 30, 2024
Q1 2024 74.1 +23.8 +47.2% Mar 31, 2024
Q4 2023 71.3 +29 +68.6% Dec 31, 2023
Q3 2023 64.3 +26.8 +71.3% Sep 30, 2023
Q2 2023 55.9 +22.3 +66.5% Jun 30, 2023
Q1 2023 50.3 +19.7 +64.2% Mar 31, 2023
Q4 2022 42.3 +13.8 +48.3% Dec 31, 2022
Q3 2022 37.6 +10.2 +37.4% Sep 30, 2022
Q2 2022 33.6 +7.65 +29.5% Jun 30, 2022
Q1 2022 30.7 +8.22 +36.7% Mar 31, 2022
Q4 2021 28.5 +9.09 +46.8% Dec 31, 2021
Q3 2021 27.3 +11.1 +68.5% Sep 30, 2021
Q2 2021 25.9 +12.3 +90.5% Jun 30, 2021
Q1 2021 22.4 +8.29 +58.7% Mar 31, 2021
Q4 2020 19.4 +5.09 +35.5% Dec 31, 2020
Q3 2020 16.2 +1.43 +9.67% Sep 30, 2020
Q2 2020 13.6 -3.54 -20.6% Jun 30, 2020
Q1 2020 14.1 -2.98 -17.4% Mar 31, 2020
Q4 2019 14.4 -1.48 -9.35% Dec 31, 2019
Q3 2019 14.8 -2 -11.9% Sep 30, 2019
Q2 2019 17.2 +2.89 +20.3% Jun 30, 2019
Q1 2019 17.1 +4.99 +41.1% Mar 31, 2019
Q4 2018 15.8 +4.96 +45.6% Dec 31, 2018
Q3 2018 16.8 +7.42 +79.1% Sep 30, 2018
Q2 2018 14.3 +5.69 +66.4% Jun 30, 2018
Q1 2018 12.1 +4.14 +51.8% Mar 31, 2018
Q4 2017 10.9 +4.07 +59.9% Dec 31, 2017
Q3 2017 9.38 +2.51 +36.6% Sep 30, 2017
Q2 2017 8.57 +1.49 +21.1% Jun 30, 2017
Q1 2017 7.99 +0.79 +11% Mar 31, 2017
Q4 2016 6.8 -1.12 -14.1% Dec 31, 2016
Q3 2016 6.86 +0.32 +4.89% Sep 30, 2016
Q2 2016 7.08 +1.67 +30.9% Jun 30, 2016
Q1 2016 7.19 +3 +71.5% Mar 31, 2016
Q4 2015 7.92 +4.63 +141% Dec 31, 2015
Q3 2015 6.54 +3.64 +125% Sep 30, 2015
Q2 2015 5.41 +2.41 +80.6% Jun 30, 2015
Q1 2015 4.19 Mar 31, 2015
Q4 2014 3.29 Dec 31, 2014
Q3 2014 2.9 Sep 30, 2014
Q2 2014 2.99 Jun 30, 2014
Q4 2012 22.7 Dec 31, 2012
Q3 2012 46.2 Sep 30, 2012
Q2 2012 43.7 Jun 30, 2012
Q1 2012 34.4 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.